|
| Title |
|
|
|
Discovery of novel, drug-like ferroptosis inhibitors with in vivo efficacy
| |
| Author |
|
|
|
| |
| Abstract |
|
|
| | |
| Language |
|
|
|
English
| |
| Source (journal) |
|
|
|
Journal of medicinal chemistry. - Washington, D.C., 1963, currens | |
| Publication |
|
|
|
Washington, D.C. : 2018
| |
| ISSN |
|
|
|
0022-2623
| |
| Volume/pages |
|
|
|
61:22(2018), p. 10126-10140
| |
| ISI |
|
|
|
000451496300019
| |
| Full text (Publisher's DOI) |
|
|
| | |
| Full text (open access) |
|
|
|
| The author-created version that incorporates referee comments and is the accepted for publication version Available from 26.10.2019 | | |
| Full text (publisher's version - intranet only) |
|
|
| | |
|
| Faculty/Department |
|
|
|
| |
| Research group |
|
|
|
| Project info |
|
|
|
Research in the field of pathophysiology. Identification, lead optimization and validation of necroptosis inhibitors. Investigating the role of ferroptosis in acute liver injury and multiple sclerosis with newly developed chemical tool compounds.
| Publication type |
|
|
| | | |
| Subject |
|
|
|
| | |
| Affiliation |
|
|
|
Publications with a UAntwerp address
| |
|
|
|
| Identification |
|
| |
|
|
| Creation |
|
| |
31.10.2018
|
|
| Last edited |
|
| |
13.02.2019
|
|
| To cite this reference |
|
|
| | |
|
| |